LONDON: Amur Minerals Corporation, now an AIM Rule 15 cash shell, has executed a sale and purchase agreement to acquire Extruded Pharmaceuticals Limited (EPL), a UK-based innovator in cancer treatment technology. The acquisition, valued at £5.5 million, will be satisfied through the issuance of 23,939,986 new ordinary shares. This strategic acquisition is a reverse takeover…